Panacea Biotec Ltd. — Board/Management Information 2026

May 29, 2026

Panacea Biotec

Innovation in support of life

May 29, 2026

The Manager, Listing Department
The National Stock Exchange of India Ltd.
Exchange Plaza, Bandra Kurla Complex,
Bandra (E), Mumbai - 400 051
NSE Symbol: PANACEABIO

BSE Limited
Corporate Relationship Department,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai - 400 001
BSE Scrip Code: 531349

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III of the said Regulations

Dear Sir/Madam,

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) read with Para A of Part A of Schedule III of the said Regulations, we would like to inform you that the Board of Directors of the Company’s material wholly owned subsidiary company viz. Panacea Biotec Pharma Limited (“PBPL”) has in its meeting held today i.e. May 29, 2026, inter-alia, approved:

1. the appointment of Mr. Krishan Kumar Jalan (DIN: 01767702) as an additional director in the capacity of non-executive independent director, not liable to retire by rotation, for a period commencing from July 01, 2026, until his current tenure as an independent director in Panacea Biotec Ltd. (“the Company”) i.e. till February 13, 2030, subject to approval from the shareholders; and
2. the re-appointment of Mrs. Manjula Upadhyay (DIN: 07137968) as a non-executive independent director, not liable to retire by rotation, for a term of 5 (five) consecutive years from July 23, 2026, to July 22, 2031, subject to approval from the shareholders.

The details as required under Regulation 30 read with Para A of Part A of Schedule III of the SEBI LODR Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are annexed herewith as Annexure - A.

This is for your kind information and record please.

Thanking you,

Sincerely yours,

For Panacea Biotec Limited

ANKIT JAIN
Digitally signed by ANKIT
Date: 2026.05.29 16:07:08
+05'30'

Ankit Jain
General Manager – Legal & Company Secretary

Encl. As above

---

Panacea Biotec

Innovation in support of life

Annexure – A

Details as required under Regulation 30 read with Para A of Part A of Schedule III of the SEBI LODR Regulations and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are as under:

S. No.	Disclosure Requirement	Mr. Krishan Kumar Jalan	Mrs. Manjula Upadhyay
1.	DIN	01767702	07137968
2.	Reason for change viz. appointment, reappointment, resignation, removal, death or otherwise	Appointment of Mr. Krishan Kumar Jalan, as an additional director in the capacity of non-executive independent director in the Company's material wholly owned subsidiary company viz. Panacea Biotec Pharma Limited (“PBPL”)	Re-appointment of Mrs. Manjula Upadhyay, as non-executive independent director in PBPL.
3.	Date of appointment / re-appointment / cessation (as applicable) & term of appointment / reappointment	Date of Appointment: July 01, 2026
Term of Appointment: From July 01, 2026 to February 13, 2030	Date of Appointment: July 23, 2026
Term of Appointment: 5 (five) years w.e.f. July 23, 2026
4.	Brief profile (in case of appointment)	Mr. Krishan Kumar Jalan, aged about 68 years, is a retired IAS. He is B.Sc. Honours, M.Sc. in Mathematics, M.Phil. in Mathematics & M. Phil. In Public Administration. He has also done Master of Social Science in Development Administration from University of Birmingham, UK. He has also attended various short-term courses including one at Columbia University.
Currently, he is acting as an independent director of the Company, PNC Infratech Ltd., Titagarh Rail Systems Ltd., Pipan Oils Ltd. Asit C Mehta Financial Services Limited and other various entities. He is also having Chairmanship & Membership in various committees thereof. He brings over 35 years of experience in the Indian Administrative Service, notably serving various senior positions including	Mrs. Manjula Upadhyay is a practicing lawyer with rich experience of around 37 years specially in the field of labour laws. She is holding directorships in The Delhi Floor Mills Company Ltd. and DTC India Ltd. She is the Managing Partner of MR Lex Corp LLP (a firm rendering consultancy services to several companies including Panacea Group)

---

Panacea Biotec

Innovation in support of life

S. No.	Disclosure Requirement	Mr. Krishan Kumar Jalan	Mrs. Manjula Upadhyay
		Additional Chief Secretary, Principal Secretary, Director of various departments of Haryana Government and Secretary to the Government of India for the Ministry of MSME. His extensive experience in governance and administration shall strengthen the decision making processes and ensure adherence to ethical practices of PBPL’s Board.
5.	Disclosure of relationships between directors (in case of appointment of a director)	Mr. Krishan Kumar Jalan is not related to any director.	Mrs. Manjula Upadhyay is not related to any director.
6.	Information as required pursuant to BSE Circular with ref no LIST / COMP / 14 / 2018-19 and the National Stock Exchange of India Ltd. with ref. no. NSE / CML / 2018 / 24, dated 20th June, 2018	Mr. Krishan Kumar Jalan is not debarred from holding the office of Director by virtue of any SEBI Order or any other such authority.	Mrs. Manjula Upadhyay is not debarred from holding the office of Director by virtue of any SEBI Order or any other such authority.

Thanking you,

Sincerely yours,

For Panacea Biotec Limited

ANKIT

JAIN

Digitally signed by

ANKIT JAIN

Date: 2026.05.29

16:08:00 +05'30'

Ankit Jain

General Manager – Legal & Company Secretary